P ersistent neurogenesis occurs in the adult mammalian brain throughout life, [1] [2] [3] including in humans. 4 Adult neurogenesis is observed in 2 limited areas: the subgranular zone (SGZ) in the hippocampus [1] [2] [3] [4] and the rostral migratory stream from the subventricular zone (SVZ) to the olfactory bulb. 5, 6 This finding suggests the potential ability of the brain to repair itself. 7 This attractive hypothesis has facilitated research into adult neurogenesis, and it has been reported that several factors affect the activity of neurogenesis in the SGZ. Neurogenesis in the hippocampus is increased by learning, running, and an enriched environment. 8 -10 Some pathological states, including adrenalectomy, 11 seizure, 12 mechanical dentate gyrus lesions, 13 and ischemic insult, 14 also increase hippocampal neurogenesis. Because ischemic brain injury frequently disrupts neural function in the central nervous system, it is very important to understand the response of neuronal progenitor cells after ischemia. Recently, Liu et al 14 reported that neurogenesis increased in the adult gerbil brain after ischemia. However, there is no direct evidence of the increased proliferation of neuronal progenitor cells after ischemia. Because many glial cells are activated and proliferate in the hippocampus after transient forebrain ischemia, a suitable marker of neuronal progenitor cells is necessary to identify BrdU-labeled cells divided from neuronal progenitor cells.
In the present study, we evaluated the (1) activity of cell proliferation in the rat SGZ after ischemia, (2) proliferation of the neuronal progenitor cells using a Musashi-1 (Msi1) antibody, (3) neuronal phenotype expression in newborn cells, and (4) influences of aging on the survival rate of postproliferation cells after ischemia. Msi1 is a neural RNAbinding protein 15 that is expressed in the neuronal progenitor cells and astrocytes in the adult mammalian brain. 16 -18 The double-labeling technique of Msi1 and glial fibrillary acidic protein (GFAP) can demonstrate neuronal progenitor cells: neuronal progenitor cells express Msi1 without GFAP immu-noreactivity. Aging influences neurogenesis in the SGZ, 19 and ischemic stroke is so common in the aged brain that we also investigated birth from progenitor cells and subsequent reduction of newborn cells in the SGZ to evaluate the influences of aging on ischemia-induced neurogenesis.
Materials and Methods

Animal Model
Adult male Wistar rats (3 to 4 months or 1 year old) were used in the present study. The experimental protocol was approved by the Institutional Animal Care and Use Committee of Osaka University Graduate School of Medicine. Transient forebrain ischemia was induced through 4-vessel occlusion and reperfusion as previously described. 20, 21 On the first day, rats were anesthetized with pentobarbital (45 mg/kg IP), and both vertebral arteries were cauterized through each alar foramen with an electrocautery needle. After recovery from anesthesia, rats had free access to water but were without food overnight. On the second day, rats were anesthetized with 1% inhaled halothane, and both common carotid arteries were occluded with miniature aneurysmal clips for 10 minutes. Only rats that showed loss of consciousness, pain reflex, and corneal reflex were chosen for the present study. Rats with respiratory distress were excluded. Rectal temperature was continuously monitored during ischemia and was maintained at 37°C to 37.5°C with an overhead heating lamp for up to 1 hour after removal of the clips. We also monitored the skull temperature with a needle thermometer probe placed on the parietal area of the skull and maintained it at 36.0°C during ischemia. Sham-operated animals went through only the procedure of the first day and carotid exposure without clipping.
Bromodeoxyuridine Labeling
We used bromodeoxyuridine (BrdU) (Boehringer Mannheim), a thymidine analog, to label proliferating cells. BrdU was incorporated into newly synthesized DNA.
We administered to the rats of the control, sham, and ischemia groups (each time point is 4, 7, 10, 14, or 28 days after ischemia; nϭ4 for each group) BrdU (50 mg/kg IP) 3 times every 4 hours over a period of 8 hours. The next day (therefore, each time point is 5, 8, 11, 15, or 29 days after ischemia, respectively), the rats were perfused transcardially with 4% paraformaldehyde (PFA) in 50 mmol/L concentration of a phosphate buffer while under deep anesthesia with pentobarbital. To evaluate the phenotype of postmitotic cells, we administered BrdU (50 mg/kg IP) 3 times 7 days after ischemia. Control and ischemic rats were perfused transcardially with 4% PFA 28 days after BrdU injection. Furthermore, we assessed the influences of aging on the birth and residual rate of newborn cells after ischemia; twenty-two 3-to 4-month-old rats and eighteen 1-year-old rats underwent this protocol. They were perfused 1 or 28 days after BrdU (50 mg/kg IP) 3 times at 7 days after ischemia.
Immunohistochemistry
After perfusion with 4% PFA, the brains were removed, cut into coronal blocks containing the hippocampus, and immediately immersion-fixed in 4% PFA. Coronal sections (30 m thick) were cut on a vibratome. The brain sections were incubated with a primary antibody diluted with TBS/0.1% Triton X-100 at 4°C overnight. After being washed in TBS/0.1% Triton X-100, the sections were incubated with a biotinylated secondary antibody for 1 hour at room temperature. They were washed and further incubated with a streptavidin-biotinperoxidase complex (Vector Laboratories). The peroxidase reaction was carried out via incubation with diaminobenzidine and hydrogen peroxide. We used the following antibodies as primary antibodies: mouse monoclonal anti-BrdU antibody (1:100; Amersham), rat monoclonal anti-BrdU antibody (1:200; Harlan Sera-Labo), mouse monoclonal anti-NeuN antibody (1:200; Chemicon), rabbit polyclonal anti-GFAP antibody (1:200; Sigma Chemical Co), and rat monoclonal Msi1 antibody. 18 For BrdU immunohistochemistry, DNA denaturing was required. Free floating sections were treated in 50% formamide and a 2ϫ saline-sodium citrate buffer at 65°C for 2 hours. After washing in the 2ϫ saline-sodium citrate buffer, sections were incubated in 2N HCl at 37°C for 30 minutes. Sections were rinsed in TBS/0.1% Triton X-100 for 20 minutes and incubated with an anti-BrdU antibody at 4°C overnight. The subsequent procedure was the same as that for other immunohistochemistry.
Double-immunostaining was performed with immunofluorescence and confocal microscopy (Zeiss). For double labeling of BrdU and cell markers (NeuN, neuron; GFAP, astrocyte; Msi1, neuronal progenitor cells and astrocytes), sections were incubated with an anti-BrdU antibody and antibodies for each cell marker at 4°C overnight after DNA denaturation. FITC-or rhodamine-labeled goat anti-IgG antibodies were used as the secondary antibodies. The combination of antibodies used in each double-immunostaining experiment was (1) rat anti-BrdU antibody and mouse anti-NeuN antibody as primary antibodies and rhodamine-labeled anti-rat IgG antibody and FITC-labeled anti-mouse IgG as secondary antibodies for BrdU-NeuN; (2) mouse anti-BrdU antibody and rabbit anti-GFAP antibody as primary antibodies and FITC-labeled anti-mouse IgG antibody and rhodamine-labeled anti-rabbit IgG antibody as secondary antibodies for BrdU-GFAP; (3) mouse anti-BrdU antibody and rat anti-Msi1 antibody as primary antibodies and FITClabeled anti-mouse IgG antibody and rhodamine-labeled anti-rat IgG antibody as secondary antibodies for BrdU-Msi1; and (4) rat antiMsi1 antibody and rabbit anti-GFAP antibody as primary antibodies and FITC-labeled anti-rat IgG antibody and rhodamine-labeled anti-rabbit IgG antibody as secondary antibodies for Msi1-GFAP.
Quantification
To count BrdU-positive cells colored by the peroxidase reaction, 5 sections from each hippocampus were obtained every 150 m beginning at a section 1.5 mm caudal to the bregma. The granular cell layer (GCL) (Ϸ60 m) and SGZ, defined as a 2-cell body wide zone (Ϸ10 m) along the border of the GCL and the hilus, were always combined for quantification. The mean density of BrdUlabeled cells in each mouse was calculated as the number of labeled nuclei divided by the area. Statistical analysis was performed using ANOVA followed by Scheffé's post hoc tests.
To assess what percentage of newborn cells acquire the neuronal phenotype after ischemia, we used a double-immunostaining technique. We detected BrdU-positive cells in the SGZ and GCL and determined whether they expressed NeuN signals with confocal microscopy. Double positive percentage was calculated as BrdU/ NeuN-positive cells for total BrdU-positive cells. The mean values for data were obtained in 8 sections from 4 rats. The ischemic group rats were administered BrdU 7 days after ischemia, and both groups of rats were killed 28 days after BrdU labeling.
Results
Cell Mitotic Activity in the Hippocampus After Transient Forebrain Ischemia
A few BrdU-positive cells were observed in the SGZ of hippocampal dentate gyrus in the control ( Figure 1A) . The temporal and regional profiles of BrdU immunoreactivity did not differ significantly between control and sham-operated animals (data not shown). The number of BrdU-positive cells started to increase 5 days after ischemia in the SGZ. Only a few BrdU-positive cells were observed Ն8 days after ischemia in the dentate hilus. However, BrdU-positive cells in the SGZ continued to increase ( Figure 1B ). In addition, BrdUpositive cells formed clusters in this region ( Figure 1C ), which suggested that these cells had divided from an original progenitor cell. Semiquantitative analysis showed that cell
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mitotic activity in the SGZ reached a peak 8 days after ischemia ( Figure 1D ), and the number of BrdU-positive cells increased Ϸ5.7-fold compared with the control. Cell mitotic activity in the SGZ declined to the level of control rats 15 days after ischemia.
Stimulation of Cell Division From the Msi1-Positive Neuronal Progenitor Cells
In the control and ischemic animals, many cells expressing Msi1 were observed in the hippocampus. Because both neuronal progenitor cells and astrocytes express Msi1, 17 it seems that the majority of Msi1-positive cells in the hippocampus are astrocytes and that some cells expressing Msi1 in the SGZ are neuronal progenitor cells. We used the double-labeling technique to distinguish these 2 cell types. We demonstrated that BrdU-positive cells colocalized with Msi1 in the SGZ (Figures 2A to 2C ), but not in the CA1 region ( Figures 2D to 2F ), 8 days after ischemia. Msi1-positive cells, which formed clusters in the SGZ, did not colocalize with GFAP ( Figures 3A to 3C ), whereas all of the Msi1-positive cells colocalized with GFAP in the CA1 region ( Figures 3D to 3F ).
Enhanced Neurogenesis in the Dentate Gyrus After Ischemia
There were no BrdU-positive cells showing immunofluorescence for GFAP or NeuN in the SGZ or GCL 8 days after the BrdU injection (data not shown). We observed that BrdUpositive postmitotic cells derived from neuronal progenitor cells expressed the neuronal antigenic phenotype 28 days after BrdU injection ( Figures 4A to 4C ). In this region, Ͼ70% of all BrdU-positive cells represented the neuronal phenotype Table 1 ). The number of newborn neurons, which could be demonstrated by BrdU-NeuN double-positive findings, on the single section clearly increased in the ischemia group compared with the control group (control 8.4Ϯ2.9, ischemia 39.5Ϯ8.2). On the other hand, BrdU-GFAP double-positive cells were rarely observed ( Figure 4D ). In this time point, the BrdU-positive cell nuclei were large and round ( Figures 4E and 4F) , which was in contrast to the immature cells immediately after proliferation, which were small and irregular ( Figure 1C ).
Effects of Aging on the Proliferation of Neuronal Progenitor Cells and Reduction in Newborn Neurons After Ischemia
Transient forebrain ischemia for 10 minutes resulted in selective neuronal death in the CA1 and CA4 sector of the hippocampus in both young (3 to 4 months old) and older (1 year old) rats. The severity of neuronal damage was similar in both groups. In the SGZ of control animals, the larger number of BrdU-positive cells was observed in the young group than in the older group 1 day after BrdU administration; the number of newborn cells, on the other hand, increased significantly after ischemia in both the young group (5.7-fold) and the older group (10.6-fold) ( Table 2) . Residual rates 28 days after BrdU injection were almost the same (60% to 80%) in the control and ischemic rats of the young group. Therefore, there were significantly more BrdU-positive cells 28 days after BrdU injection in the ischemia group than in control group in the young SGZ (Table 2 ). In contrast, the residual rate was markedly lower in the ischemic rats of the older group (15.3%) than in the control group (43.7%). Therefore, BrdU-positive cells in the older SGZ after ischemia were markedly reduced 35 days after ischemia, and the number of BrdU-positive cells after ischemia did not differ from that of the control in the older group (Pϭ0.069) ( Table  2 ). These results indicated that the mitotic activity of neuronal progenitor cells, which was responsive to ischemic injury, remained preserved even in the hippocampus of older animals. However, the reduction in newborn cells from neuronal progenitor cells was accelerated in the older animals.
Discussion
In the present study, we demonstrated that neurogenesis in the SGZ increased after transient forebrain ischemia and that postmitotic cells labeled with BrdU formed clusters and expressed Msi1, a neural progenitor cell marker, including neural stem cells and neuronal progenitor cells. [15] [16] [17] [18] Expression of the neural progenitor cell marker in the SGZ after ischemia has not been reported, and this is the first evidence of neuronal progenitor cells stimulated by ischemia. This response may be involved in the remodeling process of the hippocampus and functional recovery. Also, we showed that neurogenic cell proliferative activity was still preserved in the SGZ of 1-year-old rats. In the senior rats, however, newborn cells in the SGZ did not survive. Our findings concerned the hippocampus but also may be relevant to other brain areas because adult neurogenesis was recently reported in the cerebral cortex. 22 In addition, the present findings might provide a clue for development of the new therapeutic approach not only to control the proliferation of progenitor cells but also to preserve newborn cells. In our rat model, mitotic activity of the neuronal progenitor cells was maximum 8 days after ischemia. Liu et al 14 reported that neurogenesis was maximum 11 days after ischemia in the gerbil SGZ. This difference may be due to species differences. In addition, the gerbil is susceptible to seizure after ischemia. 23 Because seizure alone increases neurogenesis in the SGZ, seizure during and after ischemia may influence ischemiainduced neurogenesis in gerbils. 
Evidence of Increased Proliferation of Neuronal Progenitor Cells After Ischemia
In this study, we used Msi1 as the marker of neuronal progenitor cells. Msi1, a neural RNA-binding protein, was cloned by Sakakibara et al. 15 They reported that the level of Msi1 mRNA was very high in the embryonal brain and gradually decreased during the course of development. It is suggested that Msi1 may posttranscriptionally regulate the expression of common key genes that determine the fates of progenitor cells. 24 In the adult brain, Msi1 was expressed in the neural stem/neuronal progenitor cells and the astrocytes, but not in the microglia or oligodendroglia. 16 Because astrocytes expressed GFAP, neuronal progenitor cells can be detected using the Msi1/GFAP double-immunostaining technique, and neuronal progenitor cells can be demonstrated as Msi1-positive and GFAP-negative cells. Because microglia and astrocytes were activated and proliferated in the whole hippocampus after ischemia, BrdU-positive cells in the SGZ after ischemia may divide not only from progenitor cells but also from glial cells. We showed for the first time proliferation stimulation of neuronal progenitor cells after ischemia using double immunostaining, including Msi1. Nestin, an intermediate filament protein, has also been used as a marker of neural progenitor cells, including neural stem cells. 25 In the adult brain, nestin is expressed not only in neural stem cells in the subependymal zone but also in reactive astrocyte, in a similar manner as Msi1. 5, 16, 17 In our preliminary experiment, we compared immunostaining with Msi1 and nestin in the control and ischemic hippocampus. In contrast to the results of Msi1 (Figures 2 and 3 ), immunoreaction for nestin was not observed in cluster-forming progenitor cells in the SGZ.
Although immunoreaction for nestin after cerebral ischemia was previously investigated, 26, 27 no studies with a commercially available antibody (Rat-401; PharMingen) demonstrated nestin localization in the progenitor cells in the SGZ. It is probable that the progenitor cells in the SGZ, in contrast to those in the SVZ, express Msi1 but not nestin; however, future studies will be required to clarify the precise character of these cells because a recent study with transgenic mice that express green fluorescence protein (GFP) under nestin promoter demonstrated GFP signals in the SGZ. 28 Furthermore, immunostaining with Msi1 may have an advantage for double-staining with BrdU because of its nuclear localization.
Aging Affects Neurogenesis After Ischemia Through Reduction of Newborn Cells
We observed that proliferation of neuronal progenitor cells increased after ischemia even in the 1-year-old rats. Although aging is a factor that decreases neurogenesis in the adult normal SGZ, 19 our present data indicated that the decrease in neurogenesis due to aging was not due to the reduction in the neuronal progenitor cell population but rather to the disturbed survival of newborn cells. Recently, it was shown that the levels of corticosteroids were higher in the older brain and n indicates number examined. Numbers of BrdU-labeled nuclei/mm 2 are presented as meanϮSD. The significance of differences among 4 groups at 1 or 28 days after BrdU injection was determined using 2-way ANOVA with age and ischemia as independent variables, followed by Scheffé 's post hoc test. *PϽ0.05 vs control. †Increased rate after ischemia vs control. ‡No significant differences vs control. §Residual rate at 28 days compared with 1 day after BrdU injection.
that the decreasing corticosteroid levels in aged rats increased proliferation of neuronal progenitor cells but not newborn neurons expressing polysialylated isoforms of neural cell adhesion molecule. 29, 30 Therefore, it seems likely that aged brains contain factors that inhibit the survival of newborn cells. Alternatively, they lack factors that induce neuronal differentiation or support the survival of newborn cells. Because regulation of neurogenesis may be a target for therapeutic approaches for functional recovery, it is very important to explore factors that affect neurogenesis in in vivo animal models.
Is Modification of Endogenous Neurogenesis a Therapeutic Strategy for the Injured Brain?
The neuronal progenitor cells have been isolated from the adult rat and human brain and can generate new neurons under the presence of fibroblast growth factor-2 (FGF-2) or brain-derived neurotrophic factor in vitro, or both. 31,32 FGF-2 is a neurotrophic factor, and it can induce adult neurogenesis in vivo. 33, 34 FGF-2 and FGF receptors are upregulated in the dentate gyrus 7 days after transient forebrain ischemia. 35 Increases in FGF-2 and FGF receptor expressions are concomitant with proliferation of neuronal progenitor cells. In addition, other neurotrophic factors (nerve growth factor and brain-derived neurotrophic factor) could be induced after cerebral ischemia. 36 These neurotrophic factors may stimulate the proliferation of neuronal progenitors, neuronal differentiation, or neuronal survival in the SGZ after ischemia. Recently, it was reported that subcutaneous injection of basic FGF could stimulate in vivo neurogenesis in the neonatal and adult rat brain. 33 Neurotrophin administration could be a new therapeutic approach to enhance endogenous neurogenesis in patients with stroke and other central nervous system diseases. It has been reported that several factors can affect the process of neurogenesis (proliferation of neuronal progenitor cells or survival of newborn neurons) in the SGZ. Learning hippocampus-dependent tasks, 9 running, 10 and an enriched environment 8 are factors that increase neurogenesis. Interestingly, it was further demonstrated that running enhanced not only neurogenesis but also learning and synaptic plasticity. 37 Although it remains to be elucidated whether adult neurogenesis contributes to reorganization of the higher functions in the injured brain, newborn neurons and new neural circuits may lead to functional recovery with rehabilitation, which is commonly used for stroke patients.
